InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Browse the detailed record of transactions filed by Stout Jay S, Chief Technology Officer. Director active across 1 companies, notably Immunovant, Inc.. Aggregated, 16 reports have been recorded. Total volume traded: €905k. The latest transaction was disclosed on 23 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations16 total
US$69,8172,754 shares@ US$25.35120.0012% mcap15.4% of flow
Common Stock
SEC:0001764013-26-000055·
€69,8172,754 shares@ €25.35120.0012% mcap7.7% of flow
Common Stock
SEC:0001764013-26-000055:0·
US$183,4458,614 shares@ US$21.29620.0033% mcap40.6% of flow
Common Stock
SEC:0001702969-26-000006·
€183,4458,614 shares@ €21.29620.0033% mcap20.3% of flow
Common Stock
SEC:0001702969-26-000006:0·
US$43,8801,977 shares@ US$22.1950.0008% mcap9.7% of flow
Common Stock
SEC:0001702969-26-000002·
€43,8801,977 shares@ €22.1950.0008% mcap4.9% of flow
Common Stock
SEC:0001702969-26-000002:0·
US$26,0381,148 shares@ US$22.68090.0005% mcap5.8% of flow
Common Stock
SEC:0001764013-26-000002·
€26,0381,148 shares@ €22.68090.0005% mcap2.9% of flow
Common Stock
SEC:0001764013-26-000002:0·
US$41,3112,520 shares@ US$16.39320.0007% mcap9.1% of flow
Common Stock
SEC:0001764013-25-000143·
€41,3112,520 shares@ €16.39320.0007% mcap4.6% of flow
Common Stock
SEC:0001764013-25-000143:0·
US$22,2111,585 shares@ US$14.01310.0004% mcap4.9% of flow
Common Stock
SEC:0001764013-25-000138·
€22,2111,585 shares@ €14.01310.0004% mcap2.5% of flow
Common Stock
SEC:0001764013-25-000138:0·
US$43,2392,805 shares@ US$15.4150.0008% mcap9.6% of flow
Common Stock
SEC:0001764013-25-000115·
€43,2392,805 shares@ €15.4150.0008% mcap4.8% of flow
Common Stock
SEC:0001764013-25-000115:0·
US$22,3231,519 shares@ US$14.69590.0004% mcap4.9% of flow
Common Stock
SEC:0001764013-25-000108·
€22,3231,519 shares@ €14.69590.0004% mcap2.5% of flow
Common Stock
SEC:0001764013-25-000108:0·
16 of 16 declarations
About Stout Jay S
Jay S Stout is the Chief Technology Officer of Immunovant, Inc.
